to compare the level of effectiveness in attaining glycemic control while treating GDM mothers on metformin vs insulin

Comparison of degree of glycemic control achieved by treating GDM diagnosed patients diagnosed patients with metformin vs insulin and in assessing maternal and fetal outcomes:a randomised control trial : A RANDOMISED CONTROL TRIAL - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060216

Enrollment

146

Registered

2023-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E139- Other specified diabetes mellituswithout complications

Interventions

Intervention1: Metformin drug: This will be a will be a ‘RCT’, open label, two arm, parallel groups, non inferiority design randomized control trial where we will include all the nulli/multipara women

Eligibility

Inclusion criteria

Inclusion criteria: 1. To include pregnant female between 24 to 28 weeks pog having 75 gm OGTT more than 140 mg/dl but less than 200 mg/dl patients

Exclusion criteria

Exclusion criteria: 1. Deranged OGTT before 24 weeks of pregnancy 2. Patients diagnosed with MODY (modified onset diabetes in young) 3. Type 1 diabetes 4. Patients who have neuropsychiatric disorder, cardiovascular conditions or other comorbid conditions 5. Type 2 diabetes 6. GDM control on MNT and exercise

Design outcomes

Primary

Measure	Time frame
To compare the degree of glycemic control achieved by treating GDM diagnosed patients with metformin vs insulinTimepoint: from 24 to 28 weeks of gestation till delivery	—

Secondary

Measure	Time frame
to compare maternal and fetal outcomesTimepoint: from 24 weeks to 28 weeks of delivery	—

Countries

India

Contacts

Public ContactMukul Panda

AIIMS bhubaneswar

balakrishnandeepthy@gmail.com9446439373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026